1) Lise M. Chirurgia per le professione sanitarie. Tomo 1.Padova: Ed. PICCIN, 2006; 331:343.

Transcript

1 BIBLIOGRAFIA 1) Lise M. Chirurgia per le professione sanitarie. Tomo 1.Padova: Ed. PICCIN, 2006; 331:343. 2) Ministero della Salute. LO STATO DI SALUTE DELLE DONNE IN ITALIA. Primo rapporto sui Lavori della Commissione Salute Delle Donne. Roma, Marzo 2008; 129:138. 3) Rotta P. Radioterapia oncologica per Tecnici Sanitari Di Radiologia Medica. Torino: Ed. Minerva Medica, 1991; 5:9 4) Fiocca S., Netter F.H.. Fondamenti di anatomia e fisiologia umana. Milano: Ed. SORBONA, ) Lopez M. I tumori della Mammella. Società Editrice Universo: Roma; 2005; 7 13:16 67: ) Regione Piemonte. Assessorato Sanità. Tumore della Mammella. Linee Guida clinico organizzative per la Regione Piemonte: Torino; ) Charta senologica ( approccio diagnostico alla patologia mammaria). Documenti SIRM 2004, Coordinatore: Cosimo di Maggio. Padova 8) Brunner S. Infermieristica Medico Chirurgica. Casa editrice Ambrosiana: Milano; 2007; 130:137 78

2 9) P.Chiari, A. Santullo, l infermiere case manager, McGraw-Hill ) F.Gernin, V.Masi; Manuale di pianificazione infermieristica, Carrocci-Faber, ) A.Santullo; L infermiere e le innovazioni in sanità, McGraw-Hill, ) Protocollo FONCAM: I tumori della mammella. Linee Guida sulla diagnosi, il trattamento e la riabilitazione, Scientific Press; ) Guidicini P. Questionari.Interviste.Storie di vita. Come costruire gli strumenti, raccogliere le informazioni ed elaborare i dati. Ed. Franco Angeli, ) Zanetti R, Gafà L, Panneli F. et al. Cancer in Italy : incidence data froma cancer registries. Third Volume, Il Pensiero Scientifico Editore, March ) McPherson K, Steel CM, Dixon JM.Breast cancer-epidemiology, risk factors, and genetics. British Medical Journal 321: , ) Stoutjesdijk MJ, Boetes C, Jager GJ, et al: Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer. J Natl Cancer Inst 93: ,

3 17) Lehman CD, Blume JD, Weatherall P et al. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging. Cancer 103: , ) Plevritis SK, Kurian AW, Sigal BM et al. Cost-effectiveness of screening BRCA1/2 mutation Carriers with Breast Magnetic Resonance imaging JAMA 295 (20) : , ) Tavassoli FA. Ductal intraepithelial neoplasia of the breast. Virchows Arch. Mar;438(3):221-7, ) Singletary SE and Connolly JL. Breast Cancer Staging: Working With the Sixth Edition of the AJCC Cancer Staging Manual. CA Cancer J Clin; 56:37-47, ) Fitzgibbons PL, Page DL, Weaver D, et al. Prognostic factors in breast cancer. College of American Pathologists Consensus Statement Arch Pathol Lab Med. Vol 124, , ) Fonseca R, Hartmann LC, Petersen IA, et al. Ductal carcinoma in situ of the breast. Annals of Internal Medicine 127(11): , ) Lyman GH, Giuliano AE, Mark R. Somerfield MR, et al. American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer. Journal of Clinical Oncology 23: ,

4 24) Wong JS, Kaelin CM, Troyan SL, et al. Prospective study of wide excision alone for ductal carcinoma in situ of the breast. J Clin Oncol 24: , ) Veronesi U, Salvadori B, Luini A, et al. Breast conservation is a safe method in patients with small cancer of the breast: long-term results of three randomized trials on 1,973 patients. European Journal of Cancer 31A(10): , ) Recht A, Edge SB, Solin LJ, et al. Postmastectomy radiotherapy: guidelines of the American Society of Clinical Oncology. Journal of Clinical Oncology 19(5): , ) Vicini FA, Kestin L, Chen P,et al. Limited-Field Radiation Therapy in the Management of Early-Stage Breast Cancer. J Natl Cancer Inst; 95: , ) Early Breast Cancer Trialists Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365: , ) Smith IE, Dowsett M, Yap Y-S, et al. Adjuvant aromatase inhibitors for early breast cancer after chemotherapy-induced amenorrhoea:caution and suggested guidelines. J Clin Oncol 24: , ) Romond E, Perez EA.,Bryant J, et al. Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer. N Engl J Med 353: ,

5 31) Smith IC, Heys SD, Hutcheon AW, et al. Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel. J Clin Oncol. Mar 15;20(6): , ) Khatcheressian JL, Wolff AC, Smith TJ, et al. American Society of Clinical Oncology 2006 Update of the Breast Cancer Follow-Up and Management Guidelines in the Adjuvant Setting 24(31): , ) Geyer CE, Forster J, Lindquist et al. Lapatinib plus capecitabine for HER2-positive advanced breast cancer. New Engl J Med 355: , ) Rames HS, Jain S, Audisio RA: Implications of aging in surgical oncology. Cancer J 11: , ) Veronesi U, Boyle P, Goldhirsch a, et al. Breast Cancer. Lancet 365: , ) Berry DA, Cirrincione C, Henderson IC, et al. Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer. JAMA 295: , ) Gross, R. E., (2000). Breast cancer: Risk factors, screening and prevention. Seminars in Oncology Nursing. 38) Tyler T. The medical management of breast cancer. Seminars in Oncology Nursing. 82

6 39) Linee Guida AIOM Neoplasie della Mammella. Aggiornamento: dicembre ) ) ) ) ) ) 46) 47) 48) 49) 50) 83